Cargando…

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial

OBJECTIVE: Epilepsy is a chronic neurological disorder that affects 0.5%–1% of children. 30%–40% of patients are resistant to current anti-epileptic drugs. Lacosamide (LCM) appeared to be effective, safe, and well tolerated in children and adolescents. This study was aimed to evaluate whether LCM co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammadi, Tayebeh, Nasiri, Jafar, Ghazavi, Mohammad Reza, Yaghini, Omid, Hoseini, Neda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252575/ https://www.ncbi.nlm.nih.gov/pubmed/37304225 http://dx.doi.org/10.4103/jrpp.jrpp_86_21

Ejemplares similares

The Comparison of Levetiracetam and Piracetam Effectiveness on Breath-Holding Spells in Children: A Randomized Controlled Clinical Trial
por: Ghazavi, Mohammad Reza, et al.
Publicado: (2021)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

A Comparative Study on the Efficacy of Coenzyme Q10 and Amitriptyline in the Prophylactic Treatment of Migraine Headaches in Children: A Randomized Controlled Trial
por: Yaghini, Omid, et al.
Publicado: (2022)

Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
por: Liu, Wenyu, et al.
Publicado: (2023)

Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015)

Clinical Features and Outcome of Guillain-Barré Syndrome in Children
por: NASIRI, Jafar, et al.
Publicado: (2018)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Efficacy of Levetiracetam in Treatment of Childhood Stuttering
por: Ghazavi, Mohammadreza, et al.
Publicado: (2020)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Neurological outcome after arterial ischemic stroke in children
por: Nasiri, Jafar, et al.
Publicado: (2016)

Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Hou, Liyan, et al.
Publicado: (2021)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
por: Jaiswal, Binaya Kumar, et al.
Publicado: (2023)

Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography
por: Yamada, Hidetada, et al.
Publicado: (2021)

A Comparative Study on the Efficacy of Levetiracetam and Carbamazepine in the Treatment of Rolandic Seizures in Children: An Open-Label Randomized Controlled Trial
por: Ahadi, Parisa, et al.
Publicado: (2020)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain
por: Casas-Fernández, Carlos, et al.
Publicado: (2012)

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial
por: Ben‐Menachem, Elinor, et al.
Publicado: (2021)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Refractory Ventricular Tachycardia and Seizures With Lacosamide Overdose
por: Marcellino, Chris, et al.
Publicado: (2022)

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
por: Farkas, Mark Kristof, et al.
Publicado: (2023)

An Open Pilot Study of the Effect and Tolerability of Add-On Multivitamin Therapy in Patients with Intractable Focal Epilepsy
por: Chang, Hui Hua, et al.
Publicado: (2020)

Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
por: Zhao, Ting, et al.
Publicado: (2023)

Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses
por: Doğan, Ebru Apaydın, et al.
Publicado: (2018)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
por: Driessen, J.T., et al.
Publicado: (2022)

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study
por: Wechsler, Robert T, et al.
Publicado: (2014)

Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study
por: Abarrategui, Belén, et al.
Publicado: (2017)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients
por: Lu, Yan-Ting, et al.
Publicado: (2022)

Short-Term Side Effects of Low Dose Valproate Monotherapy in Epileptic Children: A Prospective Study
por: Nasr ESFAHANI, Parisa, et al.
Publicado: (2019)

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
por: Rudà, Roberta, et al.
Publicado: (2020)

Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
por: Kellinghaus, Christoph
Publicado: (2009)

Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
por: DeGiorgio, Andrew C., et al.
Publicado: (2012)

Lacosamide Precipitated Neutropenia in a Patient with Bipolar Disorder and Comorbid Epilepsy
por: Rao, Naren P., et al.
Publicado: (2018)

Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020)

Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients
por: Schaidle, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqcaug98l57i1evini5tcg5sbi